Plus Therapeutics (PSTV) Other Non Operating Income (2011 - 2022)
Plus Therapeutics (PSTV) reported Other Non Operating Income of $1000.0 for Q1 2022, down 50.0% year-over-year from $2000.0 in Q1 2021, and down 50.0% quarter-over-quarter from $2000.0 in Q4 2021.
Plus Therapeutics (PSTV) Other Non Operating Income (2011 - 2022) Analysis & Trends
Plus Therapeutics (PSTV) has 11 years of Other Non Operating Income data on file, last reported at $1000.0 in Q1 2022.
- Other Non Operating Income for Q1 2022 came in at $1000.0, down 50.0% year-over-year; the trailing twelve-month figure through Dec 2022 was $1000.0 (down 83.33% YoY), and the FY2022 annual result was $1000.0, down 83.33% from the prior year.
- Other Non Operating Income declined to $1000.0 in Q1 2022 per PSTV's latest filing, from $2000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $352000.0 in Q1 2018 and troughed at -$204000.0 in Q2 2018.
- A 4-year average of $37333.3 and a median of $2000.0 in 2021 frame the typical range for Other Non Operating Income.
- On a YoY basis, Other Non Operating Income climbed as much as 113.33% in 2018 and fell as far as 423.81% in 2018.
- A 4-year view of Other Non Operating Income shows it stood at $23000.0 in 2018, then surged by 547.83% to $149000.0 in 2019, then slumped by 98.66% to $2000.0 in 2021, then sank by 50.0% to $1000.0 in 2022.
- Business Quant data shows PSTV's Other Non Operating Income at $1000.0 in Q1 2022, $2000.0 in Q4 2021, and $2000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Plus Therapeutics | 37.48 Mn | 22.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 2,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Mar 31, 2019 | 149,000.00 |
| Dec 31, 2018 | 23,000.00 |
| Sep 30, 2018 | 9,000.00 |
| Jun 30, 2018 | -204,000.00 |
| Mar 31, 2018 | 352,000.00 |
| Dec 31, 2017 | -220,000.00 |
| Sep 30, 2017 | 5,000.00 |
| Jun 30, 2017 | 63,000.00 |
| Mar 31, 2017 | 165,000.00 |
| Dec 31, 2016 | -695,000.00 |
| Sep 30, 2016 | 54,000.00 |
| Jun 30, 2016 | 462,000.00 |
| Mar 31, 2016 | 413,000.00 |
| Dec 31, 2015 | 20,000.00 |
| Sep 30, 2015 | 199,000.00 |
| Jun 30, 2015 | -148,000.00 |